You are here

Article Text

Article menu

Download PDFPDF

Poster Presentation
Utilizing quantitative immunohistochemistry for relationship analysis of tumor microenvironment of head and neck cancer patients
  1. Zipei Feng1,
  2. Tarsem Moudgil1,
  3. Allen Cheng1,
  4. Christopher Paustian1,
  5. Rieneke van de Ven1,
  6. Christopher Dubay1,
  7. Hong-Ming Hu1,
  8. Tuan Bui2,
  9. Tyler Hulett1,
  10. Traci Hilton3,
  11. Carlo Bifulco1,
  12. Richard B Bell2 and
  13. Bernard A Fox1,4
  1. Aff1 grid.5288.70000000097585690Earle A. Chiles Research Institute, Providence Cancer Center; Department of Cancer BiologyOregon Health & Science University Portland OR USA
  2. Aff2 grid.415337.7Oral, Head and Neck Cancer Program and ClinicProvidence Cancer Center OR USA
  3. Aff3 grid.438792.3UbiVac USA
  4. Aff4 grid.5288.70000000097585690Molecular Microbiology and ImmunologyOHSU Portland, Portland OR, OR USA

https://doi.org/10.1186/2051-1426-2-S3-P258

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Meeting abstracts

    Background

    Analysis of tumor-infiltrating immune cells using quantitative immunohistochemistry (IHC) has proved to be a powerful prognostic biomarker in colon cancer [1, 2]. Similar observations have been made in patients with oral, head and neck squamous cell carcinoma (OHNSCC), where CD8 infiltration is associated with prolonged survival [3]. Recently, advancements are made in multiplex imaging and relationship analysis to better delineate suppressive mechanisms within the tumor microenvironment, which may direct immune interventions that augment tumor-specific immune response.

    Purpose

    The purpose of this investigation was to apply multiplex immunohistochemistry and objective assessment techniques to identify biomarkers that correlate with HPV status, T cell infiltrate, and patient survival. Relationships analysis between immune markers and tumor cells will also be performed to examine the dynamic interactions that occur within the tumor microenvironment.

    Methods

    92 subjects with biopsy-proven OHNSCC from different sub-sites underwent surgery with curative intent and were enrolled into this prospective, IRB approved protocol. Formalin-fixed-paraffin-embedded (FFPE) samples of patients' primary tumor or metastatic lymph nodes are obtained and stained for markers including CD4, CD8, CD137, CD163, interferon-gamma, arginase I, PD-L1, and class I, using the PerkinElmer Opal system. Images are scanned and analyzed using PerkinElmer Vectra system. Single stains are being done simultaneously using Ventana Benchmark XT and analyzed using Definiens platform.

    Results

    Preliminary results analyzed from 24 patients showed positive correlation between CD8 immune infiltrate within the tumor and HPV status (P = 0.05). Level of Arg1 within the tumor microenvironment showed a stronger correlation with HPV status (Figure 1), and inversely correlated with CD8 infiltrate (P = 0.03). Interestingly, the number of IFN-γ positive CD8 cells has no correlation with PD-L1 status in the subset of the patients that we have analyzed (Figure 2) - implying potential constitutive expression of PD-L1 in a subset of these patients.

    Figure 1
    Figure 1

    Arg1: HPV correlation.

    Figure 2
    Figure 2

    % IFN+ CD8 vs PD-L1 expression.

    Conclusion

    While still early, the technique is reproducible and can provide useful information on the relationships between various cells within the tumor microenvironment. Planned studies will assess the interplay between these markers in larger cohorts of patients with long-term follow-up, which aims to provide insights that may be exploited to develop novel therapeutic strategies that will improve outcomes of patients with OHNSCC.

    Support

    Steve and Cindy Harder, Nancy and Wes Lematta, Robert W. and Elsie Franz, Lynn and Jack Loacker and The Chiles foundation.

    References

    1. 1.↵
      1. Pages F,
      2. Berger A,
      3. Camus M,
      4. Sanchez-Cabo F,
      5. Costes A, et al
      . Effector memory Tcells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005;353:252654–66. doi:10.1056/NEJMoa051424
      OpenUrlCrossRefPubMedWeb of Science
    2. 2.↵
      1. Galon J,
      2. Costes A,
      3. Sanchez-Cabo F,
      4. Kirilovsky A, et al
      . Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313
    3. 3.↵
      1. Pretscher D,
      2. Distel LV,
      3. Grabenbauer GG,
      4. Wittlinger M,
      5. Buettner M,
      6. Niedobitek G
      . Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma. BMC Cancer. 2009;